Inhibition of PI3Kδ, a component of the pre-B-cell receptor and IL-7 receptor signaling pathways critical to B-cell development using idelalisib, enhances the effect of GC and GR activation on transcription to push GC-resistant B-ALL to apoptosis.42 Here, NR3C1 is linked to acute lymphoblastic leukemia.